Erik Magnus Ohman, MBBS

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 8678A Hafs Bldg, Durham, NC 27710
Phone (919) 681-2069
Email address ohman001@mc.duke.edu

Dr. Ohman, Professor of Medicine, received medical degrees from the Royal College of Surgeons in Ireland and the National University of Ireland (1984, Fellowship 1984-1987), and completed his training in cardiology at Duke University (1987-1991), where he has remained on faculty. In 2001, he became Chief of Cardiology at the University of North Carolina at Chapel Hill, where he founded the UNC Heart Center and became its first director. In 2005 he returned to Duke to pursue his interest in advanced coronary disease as the Director of the Program for Advanced Coronary Disease. Since that time, he has been appointed to Associate Director of the Duke Heart Center, the Kent and Siri Rawson Director for the Program for Advanced Coronary Disease, and most recently, Vice-Chair of Development and Innovation in the Department of Medicine.

Dr. Ohman’s clinical and research interests include interventional cardiology and high-risk supported PCI, and treatment of patients with advanced/complex coronary disease. He has researched how to improve patient care through the use of guidelines-based therapies and adherence, and examining global cardiovascular risk and health. He has been a participant on numerous guidelines writing committees, served on the ACC/AHA oversight committee for guidelines development, and has served on the steering committees for trials on ST-elevation myocardial infarction and non-ST-elevation ACS. He is a consultant to the National Institutes of Health, and a consultant for the FDA Advisory Panel for Cardiovascular Devices. 

Dr. Ohman has published over 600 peer-reviewed papers and three books in cardiovascular medicine. He holds three U.S. patents in reperfusion therapy. He is an associate editor for the American Heart Journal and serves on the editorial boards of the Journal of the American College of Cardiology and the American Journal of Cardiology.  He is a Fellow of the Royal College of Physicians in Ireland, the Royal Society of Medicine (U.K.), the European Society of Cardiology, the Society of Cardiac Angiography and Interventions, and the American College of Cardiology. 

Education and Training

  • M.B.B.S., Royal College of Surgeons (Ireland), 1981

Publications

Napp, L Christian, Ralf Westenfeld, Jacob E. Møller, Federico Pappalardo, Karim Ibrahim, Laurent Bonello, Charles Wilkins, et al. “Impella Mechanical Circulatory Support for Takotsubo Syndrome With Shock: A Retrospective Multicenter Analysis.” Cardiovasc Revasc Med 40 (July 2022): 113–19. https://doi.org/10.1016/j.carrev.2021.11.018.

PMID
34916157
Full Text

Figtree, Gemma A., Bjorn Redfors, Rebecca Kozor, Stephen T. Vernon, Stuart M. Grieve, Jawad Mazhar, Holger Thiele, et al. “Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors.” Jacc Cardiovasc Interv 15, no. 11 (June 13, 2022): 1167–75. https://doi.org/10.1016/j.jcin.2022.03.036.

PMID
35680197
Full Text

Han, Yaling, Bimmer E. Claessen, Shao-Liang Chen, Qiu Chunguang, Yujie Zhou, Yawei Xu, Lin Hailong, et al. “Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy.” Circ Cardiovasc Interv 15, no. 4 (April 2022): e009495. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009495.

PMID
35317615
Full Text

Dangas, George, Usman Baber, Samin Sharma, Gennaro Giustino, Samantha Sartori, Johny Nicolas, Ridhima Goel, et al. “Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study.” Eurointervention 17, no. 16 (March 18, 2022): 1330–39. https://doi.org/10.4244/EIJ-D-21-00721.

PMID
34881696
Full Text

Januzzi, James L., and E Magnus Ohman. “Underdiagnosis of Ischemic Heart Disease in New-Onset Heart Failure: A Call to Action.” J Am Coll Cardiol 79, no. 9 (March 8, 2022): 861–63. https://doi.org/10.1016/j.jacc.2022.01.003.

PMID
35241219
Full Text

Redfors, Björn, Matheus Simonato, Shmuel Chen, Flavien Vincent, Zixuan Zhang, Holger Thiele, Ingo Eitel, et al. “Ambient temperature and infarct size, microvascular obstruction, left ventricular function and clinical outcomes after ST-segment elevation myocardial infarction.” In Coron Artery Dis, 33:81–90, 2022. https://doi.org/10.1097/MCA.0000000000001099.

PMID
34569991
Full Text

Gibson, C Michael, Michael J. Mack, Victoria T. Lee, David J. Schneider, Frank W. Sellke, E Magnus Ohman, Vinod H. Thourani, et al. “Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose.” Am Heart J 245 (March 2022): 19–28. https://doi.org/10.1016/j.ahj.2021.10.188.

PMID
34736855
Full Text

Chiarito, Mauro, Usman Baber, Davide Cao, Samin K. Sharma, George Dangas, Dominick J. Angiolillo, Carlo Briguori, et al. “Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy.” Jacc Cardiovasc Interv 15, no. 3 (February 14, 2022): 282–93. https://doi.org/10.1016/j.jcin.2021.11.005.

PMID
35033468
Full Text

Mac Grory, Brian, E Magnus Ohman, Wuwei Feng, Ying Xian, Shadi Yaghi, Hooman Kamel, and Michael E. Reznik. “Advances in the management of cardioembolic stroke associated with patent foramen ovale.” Bmj 376 (February 9, 2022): e063161. https://doi.org/10.1136/bmj-2020-063161.

PMID
35140114
Full Text

Stefanini, Giulio G., Carlo Briguori, Davide Cao, Usman Baber, Samantha Sartori, Zhongjie Zhang, George Dangas, et al. “Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.” Eur Heart J 42, no. 45 (December 1, 2021): 4683–93. https://doi.org/10.1093/eurheartj/ehab533.

PMID
34423374
Full Text

Pages